Comparison of subthreshold micropulse laser treatment and PDT in patients with chronic central serous chorioretinopathy

AIM: To compare the efficacy and safety of 577nm subthreshold micropulse laser(SML)and photodynamic therapy(PDT)in patients with chronic central serous chorioretinopathy(cCSC).<p>METHODS: Thirty patients(30 eyes)with cCSC were treated in our hospital from February 2015 to April 2018. And 15 pa...

Full description

Bibliographic Details
Main Authors: Wei Shi, Gui-Sen Zhang, Yan-Nian Hui, Lei Liu, Xiao-Guang Zhang, Yan-Jie Kang, Yang Liu
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2019-06-01
Series:Guoji Yanke Zazhi
Subjects:
OCT
Online Access:http://ies.ijo.cn/cn_publish/2019/6/201906039.pdf
id doaj-00b5b8315ca24429b8b2adc0c4a31c0c
record_format Article
spelling doaj-00b5b8315ca24429b8b2adc0c4a31c0c2020-11-24T20:47:10ZengPress of International Journal of Ophthalmology (IJO PRESS)Guoji Yanke Zazhi1672-51231672-51232019-06-011961063106710.3980/j.issn.1672-5123.2019.6.39Comparison of subthreshold micropulse laser treatment and PDT in patients with chronic central serous chorioretinopathyWei Shi0Gui-Sen Zhang1Yan-Nian Hui2Lei Liu3Xiao-Guang Zhang4Yan-Jie Kang5Yang Liu6Inner Mongolia Chaoju Eye Hospital, Hohhot 010050, Inner Mongolia autonomous region, ChinaInner Mongolia Chaoju Eye Hospital, Hohhot 010050, Inner Mongolia autonomous region, ChinaDepartment of Ophthalmology, Air Force Medical University, Xijing Hospital, Xi'an 710015, ChinaThe First Hospital of China Medical University, Shenyang 110001,ChinaCo-first authors: Wei Shi and Gui-Sen ZhangInner Mongolia Chaoju Eye Hospital, Hohhot 010050, Inner Mongolia autonomous region, ChinaInner Mongolia Chaoju Eye Hospital, Hohhot 010050, Inner Mongolia autonomous region, ChinaInner Mongolia Chaoju Eye Hospital, Hohhot 010050, Inner Mongolia autonomous region, ChinaAIM: To compare the efficacy and safety of 577nm subthreshold micropulse laser(SML)and photodynamic therapy(PDT)in patients with chronic central serous chorioretinopathy(cCSC).<p>METHODS: Thirty patients(30 eyes)with cCSC were treated in our hospital from February 2015 to April 2018. And 15 patients(15 eyes)were treated with SML(577 nm)while the others were treated by PDT. The BCVA and CMT as well as complications were observed at 1, 3, 6mo after treatment.<p>RESULTS: At 1mo after treatment, BCVA was increased to 0.37±0.13 in SML group and 0.20±0.11 in PDT group(<i>t</i>=-3.93, <i>P</i><0.001); CMT was decreased to 382.80±76.54μm in SML group and 247.60±28.46μm in PDT group(<i>t</i>=-6.41, <i>P</i><0.001). Although improvements of BCVA and CMT were both achieved in two groups, improvements in PDT group were better than those in SML group. At 3mo and 6mo after treatment, both BCVA and CMT were no significant difference between the two groups(<i>P</i>>0.05). During the follow-up period, there were no obvious complications or recurrence observed.<p>CONCLUSION: Both SML(577nm)and PDT were effective and safe in the treatment of cCSC, but the theraputic effects of PDT was slightly quicker than SML. Further, with the prolongation of recovery time, the curative effects of these treatments were similar. Additionally, SML(577nm)costs was much cheaper than PDT and had no risk of injury or allergy for patients, and patients with cCSC could also be treated repeatedly using it.http://ies.ijo.cn/cn_publish/2019/6/201906039.pdfchronic central serous chorioretinopathy577nm subthreshold micropulse laserphotodynamic therapycentral macular thicknessOCT
collection DOAJ
language English
format Article
sources DOAJ
author Wei Shi
Gui-Sen Zhang
Yan-Nian Hui
Lei Liu
Xiao-Guang Zhang
Yan-Jie Kang
Yang Liu
spellingShingle Wei Shi
Gui-Sen Zhang
Yan-Nian Hui
Lei Liu
Xiao-Guang Zhang
Yan-Jie Kang
Yang Liu
Comparison of subthreshold micropulse laser treatment and PDT in patients with chronic central serous chorioretinopathy
Guoji Yanke Zazhi
chronic central serous chorioretinopathy
577nm subthreshold micropulse laser
photodynamic therapy
central macular thickness
OCT
author_facet Wei Shi
Gui-Sen Zhang
Yan-Nian Hui
Lei Liu
Xiao-Guang Zhang
Yan-Jie Kang
Yang Liu
author_sort Wei Shi
title Comparison of subthreshold micropulse laser treatment and PDT in patients with chronic central serous chorioretinopathy
title_short Comparison of subthreshold micropulse laser treatment and PDT in patients with chronic central serous chorioretinopathy
title_full Comparison of subthreshold micropulse laser treatment and PDT in patients with chronic central serous chorioretinopathy
title_fullStr Comparison of subthreshold micropulse laser treatment and PDT in patients with chronic central serous chorioretinopathy
title_full_unstemmed Comparison of subthreshold micropulse laser treatment and PDT in patients with chronic central serous chorioretinopathy
title_sort comparison of subthreshold micropulse laser treatment and pdt in patients with chronic central serous chorioretinopathy
publisher Press of International Journal of Ophthalmology (IJO PRESS)
series Guoji Yanke Zazhi
issn 1672-5123
1672-5123
publishDate 2019-06-01
description AIM: To compare the efficacy and safety of 577nm subthreshold micropulse laser(SML)and photodynamic therapy(PDT)in patients with chronic central serous chorioretinopathy(cCSC).<p>METHODS: Thirty patients(30 eyes)with cCSC were treated in our hospital from February 2015 to April 2018. And 15 patients(15 eyes)were treated with SML(577 nm)while the others were treated by PDT. The BCVA and CMT as well as complications were observed at 1, 3, 6mo after treatment.<p>RESULTS: At 1mo after treatment, BCVA was increased to 0.37±0.13 in SML group and 0.20±0.11 in PDT group(<i>t</i>=-3.93, <i>P</i><0.001); CMT was decreased to 382.80±76.54μm in SML group and 247.60±28.46μm in PDT group(<i>t</i>=-6.41, <i>P</i><0.001). Although improvements of BCVA and CMT were both achieved in two groups, improvements in PDT group were better than those in SML group. At 3mo and 6mo after treatment, both BCVA and CMT were no significant difference between the two groups(<i>P</i>>0.05). During the follow-up period, there were no obvious complications or recurrence observed.<p>CONCLUSION: Both SML(577nm)and PDT were effective and safe in the treatment of cCSC, but the theraputic effects of PDT was slightly quicker than SML. Further, with the prolongation of recovery time, the curative effects of these treatments were similar. Additionally, SML(577nm)costs was much cheaper than PDT and had no risk of injury or allergy for patients, and patients with cCSC could also be treated repeatedly using it.
topic chronic central serous chorioretinopathy
577nm subthreshold micropulse laser
photodynamic therapy
central macular thickness
OCT
url http://ies.ijo.cn/cn_publish/2019/6/201906039.pdf
work_keys_str_mv AT weishi comparisonofsubthresholdmicropulselasertreatmentandpdtinpatientswithchroniccentralserouschorioretinopathy
AT guisenzhang comparisonofsubthresholdmicropulselasertreatmentandpdtinpatientswithchroniccentralserouschorioretinopathy
AT yannianhui comparisonofsubthresholdmicropulselasertreatmentandpdtinpatientswithchroniccentralserouschorioretinopathy
AT leiliu comparisonofsubthresholdmicropulselasertreatmentandpdtinpatientswithchroniccentralserouschorioretinopathy
AT xiaoguangzhang comparisonofsubthresholdmicropulselasertreatmentandpdtinpatientswithchroniccentralserouschorioretinopathy
AT yanjiekang comparisonofsubthresholdmicropulselasertreatmentandpdtinpatientswithchroniccentralserouschorioretinopathy
AT yangliu comparisonofsubthresholdmicropulselasertreatmentandpdtinpatientswithchroniccentralserouschorioretinopathy
_version_ 1716810914423898112